非正規のビタミンKサイクルは,強力なフェロプトーシス抑制剤である
Eikan Mishima1,2, Junya Ito3, Zijun Wu4
1Institute of Metabolism and Cell Death, Helmholtz Zentrum München, Neuherberg, Germany. eikan@med.tohoku.ac.jp.
Nature
|August 3, 2022
まとめ
ビタミンKとその減少した形態は 臓器損傷と癌に関連したプロセスであるフェロプトーシスによる細胞死を防ぎます フェロプトーシス抑制タンパク質1 (FSP1) は,ビタミンKを減少させることで,この保護効果を媒介する.
科学分野:
- 生物化学
- 細胞生物学
- 分子医学
背景:
- フェロプトーシスは,鉄に依存した脂質過酸化によって引き起こされる細胞死経路である.
- フェロプトーシスの調節を理解することは,臓器損傷,退行性疾患,がん治療抵抗性の治療に不可欠です.
- グルタチオンペロキシダース-4はフェロプトーシスのレギュレータとして知られているが,他のメカニズムはほとんど不明である.
研究 の 目的:
- フェロプトーシスの感受性に影響を与える新しい細胞外的および細胞内部の要因を調査する.
- フェロプトーシスに対する 細胞保護における ビタミンKの役割を調べる
- ビタミンKの抗フェロプトーシス機能の基礎となる分子機構を特定する.
主な方法:
- 細胞死経路におけるビタミンK形態 (メナキノン,フィロキノン) の機能を調査した.
- ビタミンKの代謝における重要な酵素としてフェロプトーシス抑制タンパク質1 (FSP1) を特定した.
- FSP1のNAD (P) H-ウビキノン還元酵素の活性とビタミンKの減少を示すために生化学的測定を用いた.
- 減少したビタミンKの 抗酸化特性を調べた
主要な成果:
- 完全に減少したビタミンKは,有意な抗フェロプト性活性を示します.
- FSP1はビタミンKを 強力な抗酸化物質であるヒドロキノンに 効率的に分解します
- このFSP1媒介のビタミンK減少は,細胞を脂質過酸化とフェロプトーシスから保護する.
- ワルファリン中毒に対するビタミンKの保護効果は,FSP1依存経路によって説明される.
結論:
- ビタミンKは,FSP1媒介による減少により,フェロプトーシスの強力な阻害剤として作用する.
- FSP1はフェロプトーシスの予防に不可欠な非正規のビタミンKサイクルを確立します.
- この発見はフェロプトーシスに関わる疾患の 新しい治療法を提供します
関連する概念動画
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Oxidation of Phenols to Quinones
3.4K
In the presence of oxidizing agents, phenols are oxidized to quinones. Quinones can be easily reduced back to phenols using mild reducing agents. The electron-donating hydroxyl group enhances the reactivity of the aromatic ring, enabling oxidation of the ring even in the absence of an α hydrogen.
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
3.4K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Necrosis
4.8K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.8K
Cofactors and Coenzymes
83.3K
Enzymes require additional components for proper function. There are two such classes of molecules: cofactors and coenzymes. Cofactors are metallic ions and coenzymes are non-protein organic molecules. Both of these types of helper molecule can be tightly bound to the enzyme or bound only when the substrate binds.
83.3K
Role of Vitamins in Maintaining Bone Health
3.6K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
3.6K


